Rabab M. Abou El-Magd

Rabab M. Abou El-Magd

Auto-generated profile, based on publicly available information

Rabab M. Abou El-Magd

Department of Oncology, University of Alberta, Edmonton, AB T6G 1Z2, Canada

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2012 in Journal of Bioenergetics and Biomembranes
Verified
Journal Article
Closed access
PDF file
SSS. M. El Sayed
S. M. El Sayed
RER. M. Abou El-Magd
R. M. Abou El-Magd
YSY. Shishido
Y. Shishido
KYK. Yorita
K. Yorita
SCS. P. Chung
S. P. Chung
KFK. Fukui
K. Fukui

27 March 2009 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
RERm Abou El-Magd
Rm Abou El-Magd
HPHk Park
Hk Park
TKT. Kawazoe
T. Kawazoe
SIS. Iwana
S. Iwana
KOK. Ono
K. Ono
KFK. Fukui
K. Fukui
D-Amino acid oxidase (DAO) has been established to be involved in the oxidation of D-serine, an allosteric activator of the N-methyl-D-aspartate-type glutamate receptor in the brain, and to be associated with the onset of schizophrenia. The effect of risperidone, a benzisoxazole derivative, atypical antischizophrenic drug, on the activity of human DAO was tested using an in-vitro oxygraph system and rat C6, stable C6 transformant cells overexpressing mouse DAO (designated as C6/DAO) and pig kidney epithelial cells (LLC-PK1). Risperidone has a hyperbolic mixed-type inhibition, designated as ‘partial uncompetitive inhibition effect’, with Kivalue of 41 μM on human DAO. Risperidone exhibited a protective effect from D-amino acid induced cell death in both C6/DAO and LLC-PK1cells with 10% increase in viability. These data indicate the involvement of DAO activity in D-serine metabolism and also suggest a new mechanism of action to risperidone as antischizophrenic drug.

15 August 2009 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
KOKoji Ono
Koji Ono
YSYuji Shishido
Yuji Shishido
HPHwan Ki Park
Hwan Ki Park
TKTomoya Kawazoe
Tomoya Kawazoe
SISanae Iwana
Sanae Iwana
KFKiyoshi Fukui
Kiyoshi Fukui

9 February 2012 in Journal of Bioenergetics and Biomembranes
Verified
Journal Article
Closed access
PDF file
SSS. M. El Sayed
S. M. El Sayed
RER. M. Abou El-Magd
R. M. Abou El-Magd
YSY. Shishido
Y. Shishido
SCS. P. Chung
S. P. Chung
DIEM TRANDIEM TRAN
DIEM TRAN
KFK. Fukui
K. Fukui

16 September 2011 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
SSS M El Sayed
S M El Sayed
RER M Abou El-Magd
R M Abou El-Magd
YSY Shishido
Y Shishido
SCS P Chung
S P Chung
TST Sakai
T Sakai
KFK Fukui
K Fukui
Glioma tumors are refractory to conventional treatment. Glioblastoma multiforme is the most aggressive type of primary brain tumors in humans. In this study, we introduce oxidative stress-energy depletion (OSED) therapy as a new suggested treatment for glioblastoma. OSED utilizes D-amino acid oxidase (DAO), which is a promising therapeutic protein that induces oxidative stress and apoptosis through generating hydrogen peroxide (H2O2). OSED combines DAO with 3-bromopyruvate (3BP), a hexokinase II (HK II) inhibitor that interferes with Warburg effect, a metabolic alteration of most tumor cells that is characterized by enhanced aerobic glycolysis. Our data revealed that 3BP induced depletion of energetic capabilities of glioma cells. 3BP induced H2O2 production as a novel mechanism of its action. C6 glioma transfected with DAO and treated with D-serine together with 3BP-sensitized glioma cells to 3BP and decreased markedly proliferation, clonogenic power and viability in a three-dimensional tumor model with lesser effect on normal astrocytes. DAO gene therapy using atelocollagen as an in vivo transfection agent proved effective in a glioma tumor model in Sprague–Dawley (SD) rats, especially after combination with 3BP. OSED treatment was safe and tolerable in SD rats. OSED therapy may be a promising therapeutic modality for glioma.

27 December 2014 in Theoretical Biology and Medical Modelling
Verified
Journal Article
Open access
PDF file
Jack TuszynskiJack Tuszynski
Jack Tuszynski
PWPhilip Winter
Philip Winter
DWDiana White
Diana White
CTChih-Yuan Tseng
Chih-Yuan Tseng
KSKamlesh Sahu
Kamlesh Sahu
RERabab M Abou El-Magd
Rabab M Abou El-Magd
A variety of topics are reviewed in the area of mathematical and computational modeling in biology, covering the range of scales from populations of organisms to electrons in atoms. The use of maximum entropy as an inference tool in the fields of biology and drug discovery is discussed. Mathematical and computational methods and models in the areas of epidemiology, cell physiology and cancer are surveyed. The technique of molecular dynamics is covered, with special attention to force fields for protein simulations and methods for the calculation of solvation free energies. The utility of quantum mechanical methods in biophysical and biochemical modeling is explored. The field of computational enzymology is examined.